Mammographic Density, Estrogen Receptor Status and Other Breast Cancer Tumor Characteristics

被引:57
作者
Ding, Jane [1 ]
Warren, Ruth [1 ]
Girling, Anne [2 ]
Thompson, Deborah [3 ]
Easton, Douglas [3 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge CB2 1TN, England
[2] Norfolk & Norwich Univ Hosp, Cotman Ctr, Norwich, Norfolk, England
[3] Univ Cambridge, Strangeways Res Lab, Cambridge CB2 1TN, England
关键词
estrogen receptor; mammographic density; tumor characteristics; SURGICAL ADJUVANT BREAST; QUANTITATIVE-ANALYSIS; REPLACEMENT THERAPY; RISK; ASSOCIATION; PREVENTION; TAMOXIFEN; POLYMORPHISMS; GRADE; WOMEN;
D O I
10.1111/j.1524-4741.2010.00907.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to examine the relationship between mammographic density and histological characteristics of breast tumors within a case-control study population. This study was an expansion of a large size case-control study examining the relationship between breast density and breast cancer risk. Percent and area of breast density was assessed in 370 invasive breast cancer cases and 1904 age-matched controls, using a computer-assisted method. Associations between breast density and estrogen receptor (ER) status, histological grade, histological size, lymph node status, vascular invasion, disease extent, and Nottingham Prognostic Index were evaluated, using logistic regression. Women with 50% or greater mammographic density have a 2.63-fold risk (95% confidence interval [95% CI] = 1.78-3.87; p < 0.001) of developing breast cancer compared to women with less than 10% density. Increase in every category of percentage of breast density is also associated with a 1.45-fold risk in developing ER positive tumors relative to ER negative tumors (odds ratio [OR] = 1.02; 95% CI = 1.00-1.04; p = 0.048), and increase in every quartile of absolute area of density is associated with a 1.48-fold ER positive breast cancer risk [95% CI = 1.06-2.07; p = 0.020]. Furthermore, breast density was found to be associated with specifically ER positivity, invasion as well as invasion with in situ, histological grades 1 and 2, tumor size larger than 1.1 cm, lack of vascular invasion, lymph node positivity and negativity, and NPI less than 4.0. After stratifying the data according to mode of diagnosis, the relationship became slightly stronger in the interval cancer group. Similar results were in observed using percent density and absolute density readings. Mammographic density was a stronger risk factor for ER positive [OR = 2.94; 95% CI = 1.94-4.43; p < 0.001] than ER negative cancers when comparing breasts with greater than 50% dense region to those with less than 10% density. No other tumor characteristic had a significant correlation with breast density. These results suggest that mammographic percent density may be more strongly related to ER positive than ER negative breast cancer, but otherwise is a risk factor for breast cancer independent of other tumor characteristics.
引用
收藏
页码:279 / 289
页数:11
相关论文
共 34 条
[1]   Association between mammographic breast density and breast cancer tumor characteristics [J].
Aiello, EJ ;
Buist, DSM ;
Emily, W ;
Porter, PL .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) :662-668
[2]  
Beral V, 2006, J MED SCREEN, V13, P59, DOI 10.1258/096914106777589678
[3]   Mammographic breast density as an intermediate phenotype for breast cancer [J].
Boyd, NF ;
Rommens, JM ;
Vogt, K ;
Lee, V ;
Hopper, JL ;
Yaffe, MJ ;
Paterson, AD .
LANCET ONCOLOGY, 2005, 6 (10) :798-808
[4]   QUANTITATIVE CLASSIFICATION OF MAMMOGRAPHIC DENSITIES AND BREAST-CANCER RISK - RESULTS FROM THE CANADIAN NATIONAL BREAST SCREENING STUDY [J].
BOYD, NF ;
BYNG, JW ;
JONG, RA ;
FISHELL, EK ;
LITTLE, LE ;
MILLER, AB ;
LOCKWOOD, GA ;
TRITCHLER, DL ;
YAFFE, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) :670-675
[5]   THE QUANTITATIVE-ANALYSIS OF MAMMOGRAPHIC DENSITIES [J].
BYNG, JW ;
BOYD, NF ;
FISHELL, E ;
JONG, RA ;
YAFFE, MJ .
PHYSICS IN MEDICINE AND BIOLOGY, 1994, 39 (10) :1629-1638
[6]   Symmetry of projection in the quantitative analysis of mammographic images [J].
Byng, JW ;
Boyd, NF ;
Little, L ;
Lockwood, G ;
Fishell, E ;
Jong, RA ;
Yaffe, MJ .
EUROPEAN JOURNAL OF CANCER PREVENTION, 1996, 5 (05) :319-327
[7]   Tamoxifen and breast density in women at increased risk of breast cancer [J].
Cuzick, J ;
Warwick, J ;
Pinney, E ;
Warren, RML ;
Duffy, SW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08) :621-628
[8]  
Cuzick J, 2002, LANCET, V360, P817
[9]   Overview of the main outcomes in breast-cancer prevention trials [J].
Cuzick, J ;
Powles, T ;
Veronesi, U ;
Forbes, J ;
Edwards, R ;
Ashley, S ;
Boyle, P .
LANCET, 2003, 361 (9354) :296-300
[10]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410